OTC Markets OTCPK - Delayed Quote USD
Coloplast A/S (CLPBF)
100.00
+0.50
+(0.50%)
At close: June 12 at 8:00:00 PM EDT
Breakdown
TTM
9/30/2024
9/30/2023
9/30/2022
9/30/2021
Total Revenue
27,794,000
27,030,000
24,500,000
22,579,000
19,426,000
Cost of Revenue
9,028,000
8,761,000
8,172,000
7,050,000
6,113,000
Gross Profit
18,766,000
18,269,000
16,328,000
15,529,000
13,313,000
Operating Expense
11,290,000
10,983,000
9,483,000
8,619,000
6,958,000
Operating Income
7,476,000
7,286,000
6,845,000
6,910,000
6,355,000
Net Non Operating Interest Income Expense
-762,000
-725,000
-605,000
-199,000
-45,000
Pretax Income
6,494,000
6,395,000
6,025,000
6,127,000
6,233,000
Tax Provision
1,950,000
1,343,000
1,242,000
1,421,000
1,408,000
Net Income Common Stockholders
4,544,000
5,052,000
4,783,000
4,706,000
4,825,000
Diluted NI Available to Com Stockholders
4,544,000
5,052,000
4,783,000
4,706,000
4,825,000
Basic EPS
20.18
22.46
22.21
22.14
22.67
Diluted EPS
20.18
22.46
22.20
22.11
22.63
Basic Average Shares
225,250
224,900
215,400
212,500
212,800
Diluted Average Shares
225,250
224,900
215,500
212,800
213,200
Total Operating Income as Reported
7,510,000
7,320,000
6,771,000
6,439,000
6,155,000
Total Expenses
20,318,000
19,744,000
17,655,000
15,669,000
13,071,000
Net Income from Continuing & Discontinued Operation
4,544,000
5,052,000
4,783,000
4,706,000
4,825,000
Normalized Income
4,678,346.78
5,010,920
4,780,618
5,198,288
4,958,128
Interest Income
136,000
155,000
111,000
39,000
11,000
Interest Expense
827,000
795,000
638,000
172,000
25,000
Net Interest Income
-762,000
-725,000
-605,000
-199,000
-45,000
EBIT
7,321,000
7,190,000
6,663,000
6,299,000
6,258,000
EBITDA
8,656,000
8,480,000
7,732,000
7,229,000
7,050,000
Reconciled Cost of Revenue
9,028,000
8,761,000
8,172,000
7,050,000
6,113,000
Reconciled Depreciation
1,335,000
1,290,000
1,069,000
930,000
792,000
Net Income from Continuing Operation Net Minority Interest
4,544,000
5,052,000
4,783,000
4,706,000
4,825,000
Total Unusual Items Excluding Goodwill
-192,000
52,000
3,000
-641,000
-172,000
Total Unusual Items
-192,000
52,000
3,000
-641,000
-172,000
Normalized EBITDA
8,848,000
8,428,000
7,729,000
7,870,000
7,222,000
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-57,653.22
10,920
618
-148,712
-38,872
9/30/2021 - 8/9/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade